Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Dermochem - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Dermochem

Approved

STANDARD

Dermochem

S Kant Healthcare Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: e0b28e25f34adc49
Company: S Kant Healthcare Ltd.
Type: Standard

Approval Details

Approval Id: e0b28e25f34adc49
Drug Approval Philippines Name: Dermochem
Product Name: Dermochem
Registration Number: DRP-11531
Brand Name: Dermochem
Generic Name: Clobetasol Propionate
Dosage Form: Topical Cream
Dosage Strength: 500 mcg/g (0.05% w/w)
Manufacturer: S Kant Healthcare Ltd.
Importer: Wellchem Pharmaceutical Products
Distributor: Wellchem Pharmaceutical Products
Issuance Date: 24 March 2022
Expiry Date: 02 March 2027
Pharmacologic Category: Corticosteroid
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

e0b28e25f34adc49

Type

Standard

Back to Philippines FDA Approvals